Showing 561-570 of 7665 results for "".
- New Research Reveals Roughly 4 in 5 Acne Sufferers Have Missed Moments in Their Life Due to Acnehttps://practicaldermatology.com/news/new-research-reveals-roughly-4-in-5-acne-sufferers-have-missed-moments-in-their-life-due-to-acne/2461227/Ninety percent of moderate to severe acne sufferers said having acne-free skin would dramatically change the way they live their life, according to a new survey released today. The survey was conducted on behalf of Cutera, Inc., which offers AviClear, the first and only FDA-cleared energy-based dev…
- Nutrafol Rolls Out New Products Aimed at Balancing the Scalp Microbiomehttps://practicaldermatology.com/news/nutrafol-rolls-out-new-products-aimed-at-balancing-the-scalp-microbiome/2461225/Nutrafol is launching Scalp Microbiome Support. Nutrafol's Scalp Microbiome Support consists of a Build-Up Blocker exfoliating mask, Root Purifier shampoo, and Stress Reliever scalp essence. Similar to the gut microbiome within the body, the scalp microbiome shields hair follicles and the scalp…
- FDA Approves Dupixent for Children 6 Months to 5 Years with Moderate to Severe Atopic Dermatitishttps://practicaldermatology.com/news/fda-approves-dupixent-for-children-6-months-to-5-years-with-moderate-to-severe-atopic-dermatitis/2461224/The FDA has approved Regeneron Pharmaceuticals, Inc. and Sanofi's Dupixent (dupilumab) for children aged 6 months to 5 years with moderate to severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Regulatory…
- Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly's Lebrikizumab Atopic Dermatitis Monotherapy Trialshttps://practicaldermatology.com/news/eight-out-of-ten-patients-maintained-skin-clearance-at-one-year-in-lillys-lebrikizumab-atopic-dermatitis-monotherapy-trials/2461223/Fully 80 percent of lebrikizumab responders maintained improvements in skin clearance and atopic dermatitis disease severity at 52 weeks with once every two week and once every four week maintenance dosing, according to topline results from the Phase 3 clinical trials (ADvocate 1 and 2). Additiona…
- June 2022 Marks Scleroderma Awareness Monthhttps://practicaldermatology.com/news/june-2022-marks-scleroderma-awareness-month/2461222/June is Scleroderma Awareness Month, and "Know Scleroderma" is the National Scleroderma Foundation's theme for 2022. Throughout the month, the Foundation will post videos and photos of individuals affected by scleroderma on its Facebook, Twitter, Instagram, and LinkedIn social media accounts. …
- University of Bradford Propels Skin Microbiome Researchhttps://practicaldermatology.com/news/university-of-bradford-propels-skin-microbiome-research/2461219/University of Bradford scientists are helping open new areas of research into the skin microbiome. Much like the gut microbiome, the skin has its own community of microorganisms, whose job is to protect us from infection and maintain a healthy state. However, scientists are only now beginning to u…
- Apyx Medical Corporation Receives FDA 510(k) Clearance for Renuvion Handpiecehttps://practicaldermatology.com/news/apyx-medical-corporation-receives-fda-510k-clearance-for-renuvion-handpiece/2461216/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rh…
- 2022 Monkeypox Outbreak: Here’s What Dermatologists Need to Knowhttps://practicaldermatology.com/news/2022-monkeypox-outbreak-heres-what-dermatologists-need-to-know/2461210/As case counts of monkeypox cases increase in Europe and other parts of the globe including the US, dermatologists may have an important role to play in terms of making differential diagnoses. George Han, MD a dermatologist at Lenox Hill Hospital in New York City, spoke to Practical Dermatology® ma…
- Study: All Moisturizer Types Equally Effectivehttps://practicaldermatology.com/news/study-all-moisturizer-types-equally-effective/2461209/No one type of moisturizer is better than another, according to the Best Emollients for Eczema trial. This study, the first to directly compare different types of moisturizers, highlights the importance of patient education and choice when deciding which moisturizers to use for children with eczem…
- June Risser Named General Manager of Premium Skincare Business Unit at Crown Laboratorieshttps://practicaldermatology.com/news/june-risser-named-general-manager-of-premium-skincare-business-unit-at-crown-laboratories/2461207/June Risser is Crown Laboratories, Inc.’s new General Manager of Premium Skincare. She will lead the global business unit which includes StriVectin and Vita Liberata, and she will hold a position on the Executive Leadership Team. Prior to Crown, she was General Manager at Galderma Laboratories wh…